Clinical Trial Update: Regulatory AVAMYS Nasal Spray PMS

View source ↗

Summary

This clinical trial update notes the completion of a post-marketing surveillance study for AVAMYS nasal spray (mometasone furoate) in allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• AVAMYS Nasal Spray (mometasone furoate nasal spray)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial and Seasonal | Status: COMPLETED